Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Patient Participation × Dermatologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 12 Gastrointestinal 9 Genitourinary 4 Other hematologic neoplasm 3 Lymphoid 3 Thoracic 2 Plasma cell 2 Sarcoma 1 Head & Neck 1 Gynecologic 1 Endocrine 1 Dermatologic 1 Classical hematology 1

Conditions

Melanoma 2222 Lymphoma, T-Cell, Cutaneous 403 Skin Neoplasms 351 Carcinoma, Non-Small-Cell Lung 311 Mycosis Fungoides 277 Neoplasms 264 Keratosis, Actinic 264 Sezary Syndrome 245 Breast Neoplasms 239 Neoplasm Metastasis 233 Lymphoma, Non-Hodgkin 231 Carcinoma, Renal Cell 230 Lymphoma 228 Lymphoma, Large B-Cell, Diffuse 218 Lymphoma, Follicular 214 Leukemia, Lymphocytic, Chronic, B-Cell 214 Carcinoma, Basal Cell 209 Lymphoma, Mantle-Cell 203 Hodgkin Disease 202 Precursor Cell Lymphoblastic Leukemia-Lymphoma 201 Lymphoma, B-Cell, Marginal Zone 201 Uveal Melanoma 198 Burkitt Lymphoma 194 Lymphoma, Large-Cell, Immunoblastic 188 Colorectal Neoplasms 161 Lymphoma, Large-Cell, Anaplastic 150 Lung Neoplasms 149 Squamous Cell Carcinoma of Head and Neck 148 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 148 Ovarian Neoplasms 148

Interventions

Decision Support Techniques 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04240717 2022-11-07

PEF-Immun

University Hospital Heidelberg

Phase NA Completed

Melanoma, Patient Participation

Data powered by HemOnc (CC BY 4.0) Colophon ⚡